- Featured Product
- KD/KO Validated
ELAC2 Rekombinanter Antikörper
ELAC2 Rekombinant Antikörper für WB, FC (Intra), ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, FC (Intra), ELISA
Konjugation
Unkonjugiert
CloneNo.
240487B6
Kat-Nr. : 83468-6-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
83468-6-PBS bindet in WB, FC (Intra), ELISA ELAC2 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | ELAC2 fusion protein Ag0105 |
| Vollständiger Name | elaC homolog 2 (E. coli) |
| Berechnetes Molekulargewicht | 92 kDa |
| Beobachtetes Molekulargewicht | 97 kDa |
| GenBank-Zugangsnummer | BC004158 |
| Gene symbol | ELAC2 |
| Gene ID (NCBI) | 60528 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Putative prostate cancer susceptibility protein (ELAC2) is encoded by HPC2/ELAC2 gene. HPC2 is a potential prostate cancer predisposition gene playing a role in genetic susceptibility to prostate cancer.It is a zinc phosphodiesterase, which displays some tRNA 3'-processing endonuclease activity and probably involved in tRNA maturation, by removing a 3'-trailer from precursor tRNA.Defects in ELAC2 may be a cause of susceptibility to prostate cancer (PC).







